InterCure To Buy Strategic Assets From Cannomed On Heels Of Its NASDAQ Debut

InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) revealed on Thursday that it will buy strategic assets from Cannomed (TASE: CNMD), an Israel-based company and owner of a pharmacy chain specializing in dispensing cannabis. The price of the acquisition was not disclosed.

The news comes on the heels of the company’s debut on the NASDAQ Global Market. One of Israel’s largest cannabis companies, InterCure is vertically integrated and concentrated on pharmaceutical-grade, GMP-certified branded products and branded product offerings with 100% retail …

Full story available on Benzinga.com

More InterCure To Buy Strategic Assets From Cannomed On Heels Of Its NASDAQ Debut